Jonathan Eitan Solomon - 29 Mar 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: PHGE
Reported as of: 29 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 31 Mar 2022, 17:25:30 UTC
Prior SEC filing: 30 Jul 2021
Next SEC filing: 24 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Solomon

Key filing fact

Jonathan Eitan Solomon filed Form 4 for BiomX Inc. (PHGE) on 31 Mar 2022.

Key facts

This page summarizes Jonathan Eitan Solomon's Form 4 filing for BiomX Inc. (PHGE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 31 Mar 2022, 17:25.

Change

Previous filing in this sequence was filed on 30 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PHGE transaction Derivative

Common Stock Options - Right to Buy

Award

Transaction value: $0
Shares: +205,000
Change %
Price: $0.000000
Shares after: 205,000
Date: 29 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 205,000
Exercise price: $1.41
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.